panipenem-betamipron has been researched along with meropenem in 8 studies
Studies (panipenem-betamipron) | Trials (panipenem-betamipron) | Recent Studies (post-2010) (panipenem-betamipron) | Studies (meropenem) | Trials (meropenem) | Recent Studies (post-2010) (meropenem) |
---|---|---|---|---|---|
68 | 17 | 7 | 3,803 | 284 | 2,253 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
Fukuda, T; Furuta, Y; Minami, S; Mitsuyama, J; Nakata, M; Nomura, N; Takahata, M; Yamada, H | 1 |
Mikamo, H; Ninomiya, M; Tamaya, T | 1 |
Araake, M; Hara, T; Watabe, H | 1 |
Inoue, M; Kaku, M; Nasu, M; Sagawa, K; Yokoyama, T | 1 |
Izumi, K; Nishiyama, M; Okada, T; Takuma, T; Yokota, E | 1 |
Haruta, T; Nonoyama, M; Ouchi, K; Sakata, H; Sato, Y; Sunakawa, K; Yamaguchi, S | 1 |
Ishiwada, N; Nakamoto, T; Ohkusu, M; Sato, J; Shoji, T; Takahashi, K; Takei, H; Takeuchi, N; Yamada, N | 1 |
1 trial(s) available for panipenem-betamipron and meropenem
Article | Year |
---|---|
[Investigation on administration method of carbapenems].
Topics: Adult; Aged; beta-Alanine; Body Temperature; C-Reactive Protein; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Female; Humans; Imipenem; Leukocyte Count; Meropenem; Middle Aged; Parametritis; Thienamycins | 2002 |
7 other study(ies) available for panipenem-betamipron and meropenem
Article | Year |
---|---|
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
[In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
Topics: 4-Quinolones; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; beta-Alanine; Ceftazidime; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infusions, Intravenous; Male; Meropenem; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazines; Rats; Thienamycins; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2002 |
[Antibacterial activity of biapenem against recent clinical isolates].
Topics: Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Thienamycins | 2003 |
[Proper use of carbapenem antibiotics based on the feature in the treatment of infectious diseases (discussion)]].
Topics: Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Thienamycins; Treatment Failure | 2004 |
[Case of multiple vertebral osteomyelitis due to Streptococcus pneumoniae].
Topics: Aged; Anti-Bacterial Agents; beta-Alanine; Cervical Vertebrae; Clindamycin; Drug Therapy, Combination; Fosfomycin; Humans; Lumbar Vertebrae; Male; Meropenem; Osteomyelitis; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Thienamycins; Treatment Outcome | 2008 |
[Pediatric bacterial meningitis prognosis and antibiotic treatment].
Topics: Anti-Bacterial Agents; beta-Alanine; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Meningitis, Bacterial; Meropenem; Prognosis; Thienamycins | 2011 |
Two cases of bacterial meningitis due to meropenem-resistant Streptococcus pneumoniae: A threat of serotype 35B, ST 558 lineage.
Topics: Anti-Bacterial Agents; beta-Alanine; Cefotaxime; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pneumococcal Vaccines; Serotyping; Streptococcus pneumoniae; Thienamycins; Treatment Outcome | 2020 |